We confirmed the presence of an autocrine, feed-forward pathway between the oncogenic Hippo signaling pathway and FGFR pathway by adding FGF5 to a CCA cell line with virtually no basal YAP immunoreactivity and observed a marked increase in YAP expression. The gene discussed is FGF5; the disease is cholangiocarcinoma.